No abstract available
MeSH terms
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control*
-
Decision Support Techniques
-
Drug Administration Schedule
-
Dyslipidemias / blood
-
Dyslipidemias / complications
-
Dyslipidemias / drug therapy*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
-
Male
-
Middle Aged
-
Musculoskeletal Diseases / chemically induced*
-
Musculoskeletal Diseases / diagnosis
-
Musculoskeletal Diseases / therapy
-
Patient Selection
-
Patient-Centered Care*
-
Prognosis
-
Risk Assessment
-
Risk Factors
-
Time Factors
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors